发明名称 |
HYDRATED CRYSTALLINE FORMS OF N-[3-FLUORO-4-({6-(METHYLOXY)-7-[(3-MORPHOLIN-4-YLPROPYL)OXY]-QUINOLIN-4-YL}OXY)PHENYL]-N'-(4-FLUOROPHENYL)CYCLOPROPANE-1,1-DICARBOXAMIDE |
摘要 |
This invention relates crystalline hydrates of N-[3-fluoro-4-({6-(methyloxy)-7-[(3- morpholin-4-ylpropyl)oxy]quinolin-4-yl }oxy)phenyl]-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, Compound (I). The invention provides methods for treatment of cancer by exploiting the modulation of protein kinase activity. The invention also provides pharmaceutical compositions containing a crystalline hydrate of Compound (I) and a pharmaceutically acceptable excipient.
|
申请公布号 |
CA2792852(A1) |
申请公布日期 |
2011.09.15 |
申请号 |
CA20112792852 |
申请日期 |
2011.03.11 |
申请人 |
EXELIXIS, INC. |
发明人 |
CANNON, HILARY;KANG, FEIRONG;VOGT, FREDERICK G. |
分类号 |
C07D215/22;A61K31/47;A61P35/00 |
主分类号 |
C07D215/22 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|